ProAssurance (PRA) to Release Earnings on Thursday

ProAssurance (NYSE:PRA) is expected to be releasing its Q3 2025 results before the market opens on Thursday, November 6th. Analysts expect ProAssurance to post earnings of $0.28 per share and revenue of $268.7110 million for the quarter. Interested persons are encouraged to explore the company’s upcoming Q3 2025 earningoverview page for the latest details on the call scheduled for Friday, November 7, 2025 at 10:00 AM ET.

ProAssurance (NYSE:PRA) last issued its quarterly earnings results on Friday, May 20th. The insurance provider reported $0.04 EPS for the quarter. ProAssurance had a return on equity of 5.62% and a net margin of 4.33%.The company had revenue of $220.02 million during the quarter. On average, analysts expect ProAssurance to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

ProAssurance Stock Down 0.6%

Shares of PRA stock opened at $23.96 on Thursday. ProAssurance has a 12 month low of $13.00 and a 12 month high of $24.22. The firm has a market cap of $1.23 billion, a PE ratio of 25.48 and a beta of 0.12. The stock has a 50 day moving average of $23.92 and a 200-day moving average of $23.55. The company has a quick ratio of 0.26, a current ratio of 0.26 and a debt-to-equity ratio of 0.33.

Analyst Ratings Changes

A number of brokerages have recently commented on PRA. Weiss Ratings reiterated a “hold (c)” rating on shares of ProAssurance in a report on Wednesday, October 8th. Zacks Research upgraded ProAssurance from a “hold” rating to a “strong-buy” rating in a report on Monday, September 22nd. One research analyst has rated the stock with a Strong Buy rating, five have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $21.50.

Institutional Trading of ProAssurance

A number of institutional investors and hedge funds have recently modified their holdings of PRA. Qube Research & Technologies Ltd increased its position in shares of ProAssurance by 186.1% during the second quarter. Qube Research & Technologies Ltd now owns 1,491,060 shares of the insurance provider’s stock valued at $34,041,000 after purchasing an additional 969,833 shares during the period. Alliancebernstein L.P. increased its position in shares of ProAssurance by 26.3% during the second quarter. Alliancebernstein L.P. now owns 1,915,673 shares of the insurance provider’s stock valued at $43,735,000 after purchasing an additional 399,194 shares during the period. Squarepoint Ops LLC bought a new stake in shares of ProAssurance during the second quarter valued at approximately $6,603,000. Millennium Management LLC increased its position in shares of ProAssurance by 181.5% during the first quarter. Millennium Management LLC now owns 306,540 shares of the insurance provider’s stock valued at $7,158,000 after purchasing an additional 197,663 shares during the period. Finally, Goldman Sachs Group Inc. increased its position in shares of ProAssurance by 47.6% during the first quarter. Goldman Sachs Group Inc. now owns 511,759 shares of the insurance provider’s stock valued at $11,950,000 after purchasing an additional 165,024 shares during the period. 85.58% of the stock is currently owned by institutional investors.

ProAssurance Company Profile

ProAssurance Corporation, through its subsidiaries, provides property and casualty insurance, and reinsurance products in the United States. The company operates through Specialty Property and Casualty, Workers’ Compensation Insurance, and Segregated Portfolio Cell Reinsurance segments. It offers professional liability insurance to healthcare providers and institutions, and attorneys and their firms; medical technology liability insurance to medical technology and life sciences companies; and custom alternative risk solutions, including assumed reinsurance, loss portfolio transfers, and captive cell programs for healthcare professional liability insureds.